• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生障碍性贫血患者感染风险预测模型的开发:复发事件中的生存分析

Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events.

作者信息

Saelue Pirun, Penthinapong Thitichaya

机构信息

Hematology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

Pharmaceutical Care Training Center, Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Mueang, Chiang Mai, Thailand.

出版信息

Infect Chemother. 2024 Dec;56(4):483-491. doi: 10.3947/ic.2024.0045. Epub 2024 Aug 30.

DOI:10.3947/ic.2024.0045
PMID:39431342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11704865/
Abstract

BACKGROUND

In patients with aplastic anemia (AA), infection-related complications are the leading cause of mortality. However, limited knowledge about the predictive factors for infection in these patients exists. Thus, this study aimed to evaluate risk factors for infection and develop a risk prediction model for the occurrence of infection in patients with AA.

MATERIALS AND METHODS

Between January 2004 and December 2020, 206 patients with AA ≥15 years of age were included in this study. Survival analysis using recurrent event methodologies was conducted to identify predictive factors associated with infection, including the Anderson and Gill model; Prentice, Williams, and Peterson (PWP) Total Time model; PWP Gap Time model; marginal model; and frailty models. The best model was determined using backward stepwise regression, and internal validation was performed using the bootstrapping method with 500 re-samplings.

RESULTS

With a median follow-up of 2.95 years, the incidence rate of infection among patients with AA was 32.8 events per 100 person-years. The PWP Total Time model revealed that cirrhosis comorbidity, lymphocytes ≥80%, and previous infection increased the risk of infection, while bone marrow cellularity ≥20% offered protection. The bone marrow cellularity, lymphocyte percentage, previous infection, cirrhosis, and hematocrit (BLICH) model was generated to predict the risk of infection. The internal validation showed a good calibration of this model.

CONCLUSION

Cirrhosis, lymphocytes ≥80%, previous infection, and bone marrow cellularity <20% are risk factors for infection in patients with AA. The BLICH model can predict the risk of infection in these patients.

摘要

背景

在再生障碍性贫血(AA)患者中,感染相关并发症是主要死亡原因。然而,对于这些患者感染的预测因素了解有限。因此,本研究旨在评估感染的危险因素,并建立AA患者感染发生的风险预测模型。

材料与方法

2004年1月至2020年12月期间,本研究纳入了206例年龄≥15岁的AA患者。采用复发事件方法进行生存分析,以确定与感染相关的预测因素,包括安德森和吉尔模型;普伦蒂斯、威廉姆斯和彼得森(PWP)总时间模型;PWP间隔时间模型;边际模型;以及脆弱模型。使用向后逐步回归确定最佳模型,并采用500次重抽样的自举法进行内部验证。

结果

中位随访2.95年,AA患者的感染发生率为每100人年32.8次事件。PWP总时间模型显示,肝硬化合并症、淋巴细胞≥80%以及既往感染会增加感染风险,而骨髓细胞计数≥20%则具有保护作用。生成了骨髓细胞计数、淋巴细胞百分比、既往感染、肝硬化和血细胞比容(BLICH)模型来预测感染风险。内部验证显示该模型具有良好的校准。

结论

肝硬化、淋巴细胞≥80%、既往感染以及骨髓细胞计数<20%是AA患者感染的危险因素。BLICH模型可以预测这些患者的感染风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/11704865/a33ac14cae5a/ic-56-483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/11704865/66052a9d8f7c/ic-56-483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/11704865/a33ac14cae5a/ic-56-483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/11704865/66052a9d8f7c/ic-56-483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d23c/11704865/a33ac14cae5a/ic-56-483-g002.jpg

相似文献

1
Development of a Prediction Model for the Risk of Infection in Patients with Aplastic Anemia: Survival Analysis in Recurrent Events.再生障碍性贫血患者感染风险预测模型的开发:复发事件中的生存分析
Infect Chemother. 2024 Dec;56(4):483-491. doi: 10.3947/ic.2024.0045. Epub 2024 Aug 30.
2
Exploring and modeling recurrent birth events in Ethiopia: EMDHS 2019.探索并建模埃塞俄比亚的重复生育事件:EMDHS 2019。
BMC Pregnancy Childbirth. 2022 Aug 5;22(1):617. doi: 10.1186/s12884-022-04948-w.
3
Comparison of statistical methods for recurrent event analysis using pediatrics asthma data.利用儿科哮喘数据比较复发事件分析的统计方法。
Pharm Stat. 2020 Nov;19(6):803-813. doi: 10.1002/pst.2032. Epub 2020 Jun 2.
4
[Optimization of Mouse Model of Aplastic Anemia Induced by Pan T Lymphocytes Combined with Irradiation].[全T淋巴细胞联合照射诱导再生障碍性贫血小鼠模型的优化]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Apr;29(2):557-566. doi: 10.19746/j.cnki.issn.1009-2137.2021.02.040.
5
Comparison of statistical models for estimating intervention effects based on time-to-recurrent-event in stepped wedge cluster randomized trial using open cohort design.基于开放式队列设计的阶梯型楔形群随机试验中,估计再发事件时间的干预效果的统计模型比较。
BMC Med Res Methodol. 2022 Apr 26;22(1):123. doi: 10.1186/s12874-022-01552-6.
6
Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.基于氟达拉滨的预处理方案在接受亲缘相合供者移植的高危再生障碍性贫血患者中的疗效:来自巴基斯坦的单中心研究。
Biol Blood Marrow Transplant. 2019 Dec;25(12):2375-2382. doi: 10.1016/j.bbmt.2019.07.029. Epub 2019 Aug 5.
7
The ratio of bone marrow myeloid progenitor cell proportion to mature lymphocytes proportion can effectively differentiate aplastic anemia and hypoplastic myelodysplastic syndrome and evaluate the quality of bone marrow aspirates.骨髓髓系前体细胞比例与成熟淋巴细胞比例的比值可有效鉴别再生障碍性贫血和低增生性骨髓增生异常综合征,并评估骨髓抽吸物的质量。
Int J Lab Hematol. 2024 Dec;46(6):1077-1083. doi: 10.1111/ijlh.14346. Epub 2024 Jul 17.
8
Assessment of Hepatic Profile in Acquired Aplastic Anemia: An Experience From Pakistan.获得性再生障碍性贫血患者肝脏状况评估:来自巴基斯坦的经验
Cureus. 2022 Sep 12;14(9):e29079. doi: 10.7759/cureus.29079. eCollection 2022 Sep.
9
Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events.基于生存分析中复发性事件的表观遗传调控因子突变的原发性血小板增多症患者血栓预测模型。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241263099. doi: 10.1177/10760296241263099.
10
Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA).骨髓增生异常综合征(MDS)和再生障碍性贫血(AA)患者骨髓中淋巴细胞免疫异常的比较。
Intern Med. 2010;49(14):1349-55. doi: 10.2169/internalmedicine.49.3477. Epub 2010 Jul 15.

本文引用的文献

1
Evolution of Laboratory Diagnosis of Tuberculosis.结核病实验室诊断的演变
Clin Pract. 2024 Feb 23;14(2):388-416. doi: 10.3390/clinpract14020030.
2
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
3
Prevalence of Bacterial Urinary Tract Infection, Associated Risk Factors, and Antimicrobial Resistance Pattern in Addis Ababa, Ethiopia: A Cross-Sectional Study.
埃塞俄比亚亚的斯亚贝巴地区细菌性尿路感染的患病率、相关危险因素及抗菌药物耐药模式:一项横断面研究
Infect Drug Resist. 2023 May 16;16:3041-3050. doi: 10.2147/IDR.S402279. eCollection 2023.
4
Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections.复发性大肠埃希菌血流感染的危险因素和微生物特征。
PLoS One. 2023 Jan 10;18(1):e0280196. doi: 10.1371/journal.pone.0280196. eCollection 2023.
5
Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study.异基因造血干细胞移植治疗感染相关性重型再生障碍性贫血患者的疗效及长期随访:多中心研究。
Front Immunol. 2022 Sep 5;13:955095. doi: 10.3389/fimmu.2022.955095. eCollection 2022.
6
Cluster analysis of lymphocyte subset from peripheral blood in newly diagnosed idiopathic aplastic anaemia patients.外周血淋巴细胞亚群簇分析在新发特发性再生障碍性贫血患者中的应用。
Ann Med. 2022 Dec;54(1):2431-2439. doi: 10.1080/07853890.2022.2118367.
7
Association between hematocrit and the 30-day mortality of patients with sepsis: A retrospective analysis based on the large-scale clinical database MIMIC-IV.基于大规模临床数据库 MIMIC-IV 的回顾性分析:血细胞比容与脓毒症患者 30 天死亡率的关系。
PLoS One. 2022 Mar 24;17(3):e0265758. doi: 10.1371/journal.pone.0265758. eCollection 2022.
8
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.免疫抑制和艾曲波帕治疗重型再生障碍性贫血患者的长期结局:一项 2 期研究。
Blood. 2022 Jan 6;139(1):34-43. doi: 10.1182/blood.2021012130.
9
Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.严重再生障碍性贫血患者在发生感染后进行异基因造血干细胞移植的结果,与未发生感染的患者相比。
Bone Marrow Transplant. 2021 Oct;56(10):2591-2594. doi: 10.1038/s41409-021-01398-4. Epub 2021 Jul 3.
10
The Evolving Challenge of Infections in Cirrhosis.肝硬化中感染问题的不断演变的挑战
N Engl J Med. 2021 Jun 17;384(24):2317-2330. doi: 10.1056/NEJMra2021808.